Press Release
<< Back
CPC Introduces New Solution for High-Flow Bioprocessing Demands
"As biopharmaceutical companies face capacity pressures, there is a need for components that support production optimization, including higher flow rates and seamless system integration," said
The new 1" MPU connector enables rapid fill and emptying of bioprocessing containers, which increases efficiency for bulk liquid transfer.
A 2019 survey of 341 global biopharmaceutical experts reported that more than 60 percent of commercial manufacturer respondents expect that their facilities will experience moderate-to-severe production capacity constraints in five years. The same survey identified adding in-house capacity, whether downstream (36.3%) or upstream (25.1%), as critical for avoiding significant capacity constraints.
The new MPU 1" connector offers higher flow rates than the existing 3/4" MPU, which has delivered reliable, leak-free performance for biopharmaceutical manufacturers for more than 20 years. The new product can be used with applications requiring a 1" connector for capsule filters, single-use bioreactors, mixing and storage tanks, chromatography skids, transfer lines and more.
The MPU connector helps to maintain smooth internal flow by minimizing transitional flow disruptions and fluid turbulence during liquid transfer and reducing the risk of product shear during processing. The MPU's new dual latching mechanism enables an easy twist-to-connect design that locks securely and guards against accidental disconnects, operator handling errors and potential contamination of the fluid path.
For more information about the performance and versatility of the MPU series or any of the other 10,000+ innovative connection solutions CPC offers, please visit www.cpcworldwide.com.
About CPC:
CPC (
About Dover:
Dover is a diversified global manufacturer and solutions provider with annual revenue of approximately
CPC Contact:
(612) 564-2053
jana.stender@cpcworldwide.com
Dover Media Contact:
Adrian Sakowicz, VP, Communications
(630) 743-5039
asakowicz@dovercorp.com
Dover Investor Contact:
Andrey Galiuk, VP, Corporate Development and Investor Relations
(630) 743-5131
agaliuk@dovercorp.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/cpc-introduces-new-solution-for-high-flow-bioprocessing-demands-301090327.html
SOURCE Dover